chrX-107841027-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_012216.4(MID2):c.362G>T(p.Arg121Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000256 in 1,209,093 control chromosomes in the GnomAD database, including 1 homozygotes. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000027 ( 1 hom. 11 hem. )
Consequence
MID2
NM_012216.4 missense
NM_012216.4 missense
Scores
2
5
10
Clinical Significance
Conservation
PhyloP100: 8.19
Genes affected
MID2 (HGNC:7096): (midline 2) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to microtubular structures in the cytoplasm. Alternate splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.27583808).
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MID2 | NM_012216.4 | c.362G>T | p.Arg121Leu | missense_variant | 2/10 | ENST00000262843.11 | NP_036348.2 | |
MID2 | NM_001382751.1 | c.302G>T | p.Arg101Leu | missense_variant | 2/10 | NP_001369680.1 | ||
MID2 | NM_052817.3 | c.362G>T | p.Arg121Leu | missense_variant | 2/10 | NP_438112.2 | ||
MID2 | NM_001382752.1 | c.302G>T | p.Arg101Leu | missense_variant | 2/10 | NP_001369681.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MID2 | ENST00000262843.11 | c.362G>T | p.Arg121Leu | missense_variant | 2/10 | 1 | NM_012216.4 | ENSP00000262843 | ||
MID2 | ENST00000443968.2 | c.362G>T | p.Arg121Leu | missense_variant | 2/10 | 1 | ENSP00000413976 | P1 | ||
MID2 | ENST00000451923.1 | c.302G>T | p.Arg101Leu | missense_variant | 2/2 | 3 | ENSP00000410730 |
Frequencies
GnomAD3 genomes AF: 0.00000900 AC: 1AN: 111114Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33328
GnomAD3 genomes
AF:
AC:
1
AN:
111114
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33328
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000655 AC: 12AN: 183108Hom.: 1 AF XY: 0.0000592 AC XY: 4AN XY: 67580
GnomAD3 exomes
AF:
AC:
12
AN:
183108
Hom.:
AF XY:
AC XY:
4
AN XY:
67580
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000273 AC: 30AN: 1097979Hom.: 1 Cov.: 32 AF XY: 0.0000303 AC XY: 11AN XY: 363343
GnomAD4 exome
AF:
AC:
30
AN:
1097979
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
363343
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000900 AC: 1AN: 111114Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33328
GnomAD4 genome
AF:
AC:
1
AN:
111114
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
7
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.362G>T (p.R121L) alteration is located in exon 2 (coding exon 2) of the MID2 gene. This alteration results from a G to T substitution at nucleotide position 362, causing the arginine (R) at amino acid position 121 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N
REVEL
Benign
Sift
Benign
T;D;D
Sift4G
Benign
T;T;T
Polyphen
0.076, 0.038
.;B;B
Vest4
0.21, 0.39
MutPred
0.26
.;Loss of glycosylation at S120 (P = 0.0873);Loss of glycosylation at S120 (P = 0.0873);
MVP
MPC
0.63
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at